title: Diabetic neuropathy: Part 2.
abstract: To conclude, effective management of hyperglycaemia, symptom control, and prevention of foot ulcers and infection through screening and surveillance remain mainstays of diabetic neuropathy management. Traditional and rational diabetic neuropathy treatments will be supplemented by novel cell based therapy and targeted drug delivery systems in the future.
authors.forename: Anu
authors.initials: A
authors.lastname: Gupta
authors.forename: Yashdeep
authors.initials: Y
authors.lastname: Gupta
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D017719:Diabetic Foot / Q000517:prevention & control; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D018384:Oxidative Stress / Q000187:drug effects; D012236:Rhodanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D053778:Thiazolidines / Q000627:therapeutic use
chemical_list: D000929:Antidepressive Agents, Tricyclic; D004791:Enzyme Inhibitors; D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine